Bladder Cancer - Results from #40

The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer. January 12, 2023

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors. January 12, 2023

Avelumab and Talazoparib Treatment in Patients with Advanced Urothelial Cancer - Expert Commentary January 11, 2023

How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience. January 11, 2023

Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer. January 11, 2023

Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0. January 10, 2023

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis. January 10, 2023

Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer. January 10, 2023

Safety and Efficacy of Rogaratinib Versus Chemotherapy in Advanced Bladder Cancer - Expert Commentary January 9, 2023

FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/ 3 mRNA Expression January 9, 2023

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. January 9, 2023

Pathological pelvic lymph node involvement in muscle-invasive bladder patients treated with radical cystectomy: A narrative review. January 9, 2023

Quality of Life and Symptom Burden in Bladder Cancer Patients Receiving Immunotherapy - Expert Commentary January 6, 2023

Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival January 6, 2023

CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy. January 6, 2023

Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab. January 6, 2023

Treatment of BCG-Unresponsive NMIBC with IL-15 Superagonist - Expert Commentary January 5, 2023

Longitudinal associations of adherence to lifestyle recommendations and health-related quality of life in patients with non-muscle invasive bladder cancer. January 5, 2023

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. January 5, 2023

Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review. January 4, 2023

Page 3 of 453

email news signup